Markë tregtare · Shqipëri

ELEVIDYS (AL/M/1/1576513)

Marka «ELEVIDYS», në pronësi të Sarepta Therapeutics, Inc., është depozituar në DPPI më 11.01.2022 për klasën 5; statusi: e regjistruar.

Përmbledhja e markës

Statusi

E regjistruar

Zyra

Drejtoria e Përgjithshme e Pronësisë Industriale (DPPI)

Nr. i aplikimit

AL/M/1/1576513

Nr. i regjistrimit

AL/M/1/1576513

ID në DPPI

346561

Lloji i markës

Verbale

Klasat Nice

5

Datat

Data e depozitimit

11.01.2022

Data e regjistrimit

13.01.2023

Data e skadimit

13.10.2030

Pronari

Emri

Sarepta Therapeutics, Inc.

Adresa

215 First Street Cambridge MA 02142

Shteti

ALBANIA

Përfaqësuesi

Emri

Maury M. Tepper, III Tepper & Eyster, PLLC

Adresa

3724 Benson Drive Raleigh NC 27609 , US

Mallrat dhe shërbimet

Klasa Nice 5 — Farmaceutikë

Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; pharmaceutical preparations that modulate rna expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; gene therapy products for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; viruses, viral vectors and viral constructs, all of the foregoing used as delivery agents, for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.

Kronologjia

1. 11.01.2022 — Aplikim i depozituar: Marka u depozitua me numër aplikimi: AL/M/1/1576513
2. 13.01.2023 — Regjistruar: Marka u regjistrua me numër regjistrimi: AL/M/1/1576513
3. 13.10.2030 — Data e skadencës / Rinovimi: Marka skadon më 13.10.2030 (1440 ditë)

Të dhëna zyrtare nga Drejtoria e Përgjithshme e Pronësisë Industriale (DPPI). Regjistrimi te zyra